Feb 15, 2013, 04.58 PM | Source: CNBC-TV18
Sudarshan Sukhani, s2analytics.com advises traders to avoid Dr Reddys.
Sudarshan Sukhani (more)
Technical Analyst, s2analytics.com | Capital Expertise: Equity - Technical
Net Sales are expected to increase by 4.6 percent
Net Sales are expected to increase by 0.4 percent
US Food and Drug Administration (USFDA) will re-au
Nomura has a buy ratings on Dr Reddy’s, Glenmark